SPOTLIGHT -
Research and Markets Releases 2022 Digital Biomarkers Drug Development Market Report
Study focuses on three major therapy areas; neurology, oncology, and cardiology, which digital biomarkers impact.
Study in Japan with Akili’s Digital Treatment for Children’s ADHD
Data in Lupus: Digital Therapeutic Improves Executive Function in Patients
Innovative Trials Opens First US Office to Support Patient Access to Clinical Trials
Personal Health Trackers May Include Smart Face Mask
Swing Selects Curavit to Provide Virtual Trial Site Services for Fibromyalgia
Astorg Acquires Majority Interest in Avania
Healthcare Leaders Unite for Digital Health Products
Alimentry Receives US FDA Clearance for Gastric Alimetry
DTA and Healthware Partner to Build European Coalition for Digital Therapeutics
Almac Announces $250 Million Global Expansion Plans
ObvioHealth Completes Virtual Urogynecology Clinical Trial
Pasithea Collaborates with Glimpse
Ferrer Announces Distribution Agreement with United Therapeutics for Tyvaso
FDA Approves Launch for Largest Clinical Trial for tDCS Device to Treat Depression
BrightInsight Launches Digital Disease Management Solution
Temedica Collaboration with BMS for Psoriasis Digital Companion
Partnership to Commercialize Prescription Digital Therapeutics in Asia
AARDEX Group Joins IT4Anxiety Project
Increasing the Adoption of Actigraphy Sensors and PSG Devices for Sleep-Disorders